Preliminary analysis of genes involved in inflammatory, oxidative processes and CA2+signaling in bipolar disorder and comorbidity for substance use disorder

Clinical Neuropsychiatry

Volumn 8, Issue 6, 2011, Pages 347-353

  Mandelli, Laura ^a   Mazza, Marianna ^b   Marangoni, Ciro ^a   di Nicola, Marco ^b   Martinotti, Giovanni ^c   Tavian, Daniela ^b   Colombo, Elisa ^b   Missaglia, Sara ^b   Negri, Gloria ^a   de Ronchi, Diana ^a   Colombo, Roberto ^b,c   Janiri, Luigi ^b   Serretti, Alessandro ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITÀ CATTOLICA DEL SACRO CUORE   (Italy)

Author keywords

Bipolar depression; Gene; Il1b; Nos1ap; Substance related disorders; Trpm2

Indexed keywords

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; COMORBIDITY; CONTROLLED STUDY; FEMALE; GENE; GENETIC ANALYSIS; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INTERLEUKIN 1 BETA GENE; MAJOR CLINICAL STUDY; MALE; NEURONAL NITRIC OXIDE ADAPTOR PROTEIN GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SUBSTANCE ABUSE; TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL 2 GENE;

EID: 84856795717     PISSN: 17244935     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Antkiewicz-Michaluk L (1999). Voltage-operated calcium channels: characteristics and their role in the mechanism of action of psychotropic drugs. Polish journal of pharmacology 51, 2, 179-186
2. Barrett JC, Fry B, Maller J and Daly MJ (2005). Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 2, 263-265
3. Benjamini Y, Drai D, Elmer G, Kafkafi N and Golani I (2001). Controlling the false discovery rate in behavior genetics research. Behavioural Brain Research 125, 1-2, 279-284
4. Cassidy F, Ahearn E and Carroll BJ (2001). A prospective study of inter-episode consistency of manic and mixed subtypes of bipolar disorder. Journal of Affective Disorders 67, 1-3, 181-185
5. Cui H, Nishiguchi N, Yanagi M, Fukutake M, Mouri K et al. (2010). A putative cis-acting polymorphism in the NOS1 gene is associated with schizophrenia and NOS1 immunoreactivity in the postmortem brain. Schizophrenia Research 121, 1-3, 172-178
6. Drago A, Liappas I, Petio C, Albani D, Forloni G et al. (2009). Epistasis between IL1A, IL1B, TNF, HTR2A, 5-HTTLPR and TPH2 Variations Does Not Impact Alcohol Dependence Disorder Features. International Journal of Environmental Research and Public Health 6, 7, 1980-1990
7. Du J, Xie J and Yue L (2009). Intracellular calcium activates TRPM2 and its alternative spliced isoforms. Proceedings of the National Academy of Science U S A 106, 17, 7239-7244
8. Fallin MD, Lasseter VK, Avramopoulos D, Nicodemus KK, Wolyniec PS et al. (2005). Bipolar I Disorder and Schizophrenia: A 440-Single-Nucleotide Polymorphism Screen of 64 Candidate Genes among Ashkenazi Jewish Case-Parent Trios. American Journal of Human Genetics 77, 6, 918-936
9. First MB, Spitzer RL, Gibbon M, Williams BW and Benjamin L (1990). Structured Clinical Interview for DSM-IVAxis II Personality Disorders (SCID-II). New York: Biometrics Research Department, New York State Psychiatric Institute.
10. First MB, Spitzer RL, Gibbon M and Williams JB (1995). Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition (SCID - I/P, Version 2.0). New York: Biometrics Research Department, New York State Psychiatric Institute.
11. Frye MA and Salloum IM (2006). Bipolar disorder and comorbid alcoholism: prevalence rate and treatment considerations. Bipolar Disorder 8, 6, 677-685
12. Garcia-Bueno B, Caso JR and Leza JC (2008). Stress as a neuroinflammatory condition in brain: damaging and protective mechanisms. Neuroscience and biobehavioral reviews 32, 6, 1136-1151
13. Gerlach M, Blum-Degen D, Ransmayr G, Leblhuber F, Pedersen V et al. (2001). Expression, but not activity, of neuronal nitric oxide synthase is regionally increased in the alcoholic brain. Alcohol and alcoholism 36, 1, 65-69
14. Goldberg JF, Garno JL, Leon AC, Kocsis JH and Portera L (1999). A history of substance abuse complicates remission from acute mania in bipolar disorder. Journal of Clinical Psychiatry 60, 11, 733-740
15. Gorwood P, Bellivier F, Ades J and Leboyer M (2000). The DRD2 gene and the risk for alcohol dependence in bipolar patients. European Psychiatry 15, 2, 103-108
16. Herold M, Meise U, Gunther V, Rossler H and Zangerle R (1994). Serum concentrations of circulating endogenous granulocyte-macrophage colony-stimulating factor in HIV- 1-seropositive injecting drug users. La Presse Médicale 23, 40, 1854-1858
17. Herraez-Baranda LA, Carretero J, Gonzalez-Sarmiento R, Laorden ML, Milanes MV et al. (2005). Evidence of involvement of the nNOS and the kappa-opioid receptor in the same intracellular network of the rat periaqueductal gray that controls morphine tolerance and dependence. Brain research 137, 1-2, 166-173
18. Hoekstra R, Fekkes D, Pepplinkhuizen L, Loonen AJ, Tuinier S et al. (2006). Nitric oxide and neopterin in bipolar affective disorder. Neuropsychobiology 54, 1, 75-81
19. Jaffrey SR, Snowman AM, Eliasson MJ, Cohen NA and Snyder SH (1998). CAPON: a protein associated with neuronal nitric oxide synthase that regulates its interactions with PSD95. Neuron 20, 1, 115-124
20. Jang MH, Shin MC, Kim EH and Kim CJ (2002). Acute alcohol intoxication decreases cell proliferation and nitric oxide synthase expression in dentate gyrus of rats. Toxicology letters 133, 2-3, 255-262
21. Jimenez-Ortega V, Cardinali DP, Poliandri AH, Cano P, Toso CF et al. (2007). 24-Hour rhythm in gene expression of nitric oxide synthase and heme-peroxidase in anterior pituitary of ethanol-fed rats. Neuroscience Letters 425, 2, 69-72
22. Johnson C, Drgon T, McMahon FJ and Uhl GR (2009). Convergent genome wide association results for bipolar disorder and substance dependence. American Journal of Medical Genetics B: Neuropsychiatric Genetics 150B, 2, 182-190
23. Kato T (2007). Molecular genetics of bipolar disorder and depression. Psychiatry and Clinical Neuroscience 61, 1, 3-19
24. Katsumata S, Minami M, Nakagawa T and Satoh M (1995). Intracisternal administration of interleukin-1 beta attenuates naloxone-precipitated withdrawal in morphine- dependent mice. European journal ofpharmacology 278, 2, 143-150
25. Knijff EM, Breunis MN, Kupka RW, de Wit HJ, Ruwhof C et al. (2007). An imbalance in the production of IL-1beta and IL-6 by monocytes of bipolar patients: restoration by lithium treatment. Bipolar Disorder 9, 7, 743-753
26. Mazza M, Mandelli L, Di Nicola M, Harnic D, Catalano V et al. (2009). Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow- up. Journal of Affective Disorders115, 27-35
27. McCarthy L, Wetzel M, Sliker JK, Eisenstein TK and Rogers TJ (2001). Opioids, opioid receptors, and the immune response. Drug and alcohol dependence 62, 2, 111-123
28. McQuillin A, Bass NJ, Kalsi G, Lawrence J, Puri V et al. (2006). Fine mapping of a susceptibility locus for bipolar and genetically related unipolar affective disorders, to a region containing the C21ORF29 and TRPM2 genes on chromosome 21q22.3. Molecular psychiatry 11, 2, 134-142
29. Misener VL, Gomez L, Wigg KG, King N, Kiss E et al. (2009). Tagging SNP association study of the IL-1beta gene (IL1B). and childhood-onset mood disorders. American Journal of Medical Genetics B: Neuropsychiatric Genetics 150B, 5, 653-659
30. Muller DJ, Likhodi O and Heinz A (2010). Neural markers of genetic vulnerability to drug addiction. Current topics in behavioral neurosciences 3, 277-299
31. Oliveira RM, Guimaraes FS and Deakin JF (2008). Expression of neuronal nitric oxide synthase in the hippocampal formation in affective disorders. Brazilian journal of medical and biological research 41, 4, 333-341
32. Ortiz-Dominguez A, Hernandez ME, Berlanga C, Gutierrez- Mora D, Moreno J et al. (2007). Immune variations in bipolar disorder: phasic differences. Bipolar Disorders 9, 6, 596-602
33. Palomo T, Kostrzewa RM, Beninger RJ and Archer T (2007). Genetic variation and shared biological susceptibility underlying comorbidity in neuropsychiatry. Neurotoxicity research 12, 1, 29-42
34. Papiol S, Molina V, Desco M, Rosa A, Reig S et al. (2008). Gray matter deficits in bipolar disorder are associated with genetic variability at interleukin-1 beta gene (2q13). Genes Brain & Behavior 7, 7, 796-801
35. Pastor IJ, Laso FJ, Romero A and Gonzales-Sarmiento R (2005). Interleukin-1 Gene Cluster Polymorphisms and Alcoholism in Spanish Men. Alcohol and Alcoholism 40, 3, 181-186
36. Petrasek J, Hubacek JA, Stickel F, Sperl J, Berg T et al. (2009). Do common genetic variants in endotoxin signaling pathway contribute to predisposition to alcoholic liver cirrhosis? Clinical Chemistry and Laboratory Medicine 47, 4, 398-404
37. Rao JS, Harry GJ, Rapoport SI and Kim HW (2010). Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Molecular psychiatry 15, 4, 384-392
38. Sadeghipour H, Ghasemi M, Nobakht M, Ebrahimi F and Dehpour AR (2007). Effect of chronic lithium administration on endothelium-dependent relaxation of rat corpus cavernosum: the role of nitric oxide and cyclooxygenase pathways. British Journal of Urology International 99, 1, 177-182
39. Serretti A and Mandelli L (2008). The genetics of bipolar disorder: genome 'hot regions,' genes, new potential candidates and future directions. Molecular psychiatry 13, 8, 742-771
40. Shinkai T, Ohmori O, Hori H and Nakamura J (2002). Allelic association of the neuronal nitric oxide synthase (NOS1). gene with schizophrenia. Molecular psychiatry 7, 6, 560-563
41. Silberberg G, Ben-Shachar D and Navon R (2010). Genetic analysis of nitric oxide synthase 1 variants in schizophrenia and bipolar disorder. American Journal of Medical Genetics B: Neuropsychiatric Genetics 153B, 7, 1318-1328
42. Smoller JW and Finn CT (2003). Family, twin, and adoption studies of bipolar disorder. American Journal of Medical Genetics C: Seminars in Medical Genetics 123C, I, 48-58
43. StatSoft I (1995). STATISTICA per Windows. StatSoft Italia srl.
44. Steckert AV, Valvassori SS, Moretti M, Dal-Pizzol F and Quevedo J (2010). Role of oxidative stress in the pathophysiology of bipolar disorder. Neurochemical research 35, 9, 1295-1301
45. Szczepankiewicz A, Dmitrzak-Weglarz M, Skibinska M, Slopien A, Leszczynska-Rodziewicz A et al. (2007). Study of dopamine receptors genes polymorphisms in bipolar patients with comorbid alcohol abuse. Alcohol and alcoholism 42, 2, 70-74
46. Takamatsu M, Yamauchi M, Maezawa Y, Saito S, Maeyama S et al. (2000). Genetic polymorphisms of interleukin-lbeta in association with the development of alcoholic liver disease in Japanese patients. The American journal of gastroenterology 95, 5, 1305-1311
47. Tang W, Huang K, Tang R, Zhou G, Fang C et al. (2008). Evidence for association between the 5' flank of the NOS1 gene and schizophrenia in the Chinese population. International Journal of Neuropsychopharmacology 11, 8, 1063-1071
48. Warsh JJ, Andreopoulosa SD and Li PP (2004). Role of intracellular calcium signaling in the pathophysiology and pharmacotherapy of bipolar disorder: current status. Clinical Neuroscience Research 4, 3-4, 201-213
49. Wood SJ, Yucel M, Pantelis C and Berk M (2009). Neurobiology of schizophrenia spectrum disorders: the role of oxidative stress. Annals of the Academy of Medicine, Singapore 38, 5, 396-396
50. Wratten NS, Memoli H, Huang Y, Dulencin AM, Matteson PG et al. (2009). Identification of a schizophrenia-associated functional noncoding variant in NOS1AP. American Journal of Psychiatry 166, 4, 434-441
51. Xu B, Wratten N, Charych EI, Buyske S, Firestein BL et al. (2005). Increased expression in dorsolateral prefrontal cortex of CAPON in schizophrenia and bipolar disorder. PLoS Medicine 2, 10, e263
52. Yanik M, Vural H, Tutkun H, Zoroglu SS, Savas HA et al. (2004). The role of the arginine-nitric oxide pathway in the pathogenesis of bipolar affective disorder. European Archives pf Psychiatry and Clinical Neuroscience 254, 1, 43-47
53. Yasseen B, Kennedy JL, Zawertailo LA and Busto UE (2010). Comorbidity between bipolar disorder and alcohol use disorder: association of dopamine and serotonin gene polymorphisms. Psychiatry Research 176, 1, 30-33
54. Yu YW, Chen TJ, Hong CJ, Chen HM and Tsai SJ (2003). Association Study of the Interleukin-1beta (C-511T). Genetic Polymorphism with Major Depressive Disorder, Associated Symptomatology, and Antidepressant Response. Neuropsychopharmacology 28, 6, 1182-1185.